DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
47 hedge funds and large institutions have $3.2M invested in DMK Pharmaceuticals Corporation Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
47
Holding in Top 10
–
Calls
$17K
Puts
–
Top Buyers
| 1 | +$1.68M | |
| 2 | +$37.9K | |
| 3 | +$14.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$10.1K |
| 5 |
Morgan Stanley
New York
|
+$1.35K |
Top Sellers
| 1 | -$17K | |
| 2 | -$16.4K | |
| 3 | -$9K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.62K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$389 |